Publication | Closed Access
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.
71
Citations
0
References
2006
Year
Renal cancer and melanoma displayed separate prognostic indicators with respect to response from interleukin-2 therapy. Although significant correlates to response were identified, there was much variability and a reliable predictive model of response to therapy could not be formulated based on these results.